Kristian Reich, Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX), sold 16,105 shares at $20.01 ($322K) on 2026-07-15, disclosed to the SEC on 2026-07-20.
Scheduled sale ($322k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MLTX | SELL | 2026-07-21 | $878K | — | Filing → |
| MLTX | SELL | 2026-06-17 | $2.9M | — | Filing → |
| MLTX | SELL | 2025-12-10 | $4.1M | — | Filing → |